Everhart Financial Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
Everhart Financial Group's BMY Position: Q2 2026 in Review
Everhart Financial Group reduced its Bristol-Myers Squibb (BMY) stake by 5.9% in Q2 2026, selling an estimated $75.5K and leaving 21,040 shares worth $1.21M. The position accounts for 0.08% of the portfolio, ranked #141.
Everhart Financial Group first reported a position in BMY in Q1 2022 and has held it in 15 quarters since. The position peaked at $1.36M in Q1 2026. 888 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Everhart Financial Group held 21,040 shares of Bristol-Myers Squibb worth $1.21M as of Q2 2026.
- Everhart Financial Group sold 1,315 Bristol-Myers Squibb shares in Q2 2026, an estimated $75.5K.
- Bristol-Myers Squibb made up 0.08% of Everhart Financial Group's portfolio in Q2 2026, its #141 holding.
- Everhart Financial Group first reported a position in Bristol-Myers Squibb in Q1 2022 and has held it in 15 quarters since.
- Everhart Financial Group's Bristol-Myers Squibb position peaked at $1.36M in Q1 2026.
- 888 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Everhart Financial Group's 13F filing for Q2 2026, filed 9 Jul 2026.